Skip to main content
. 2019 Feb 22;11(3):394–405. doi: 10.4168/aair.2019.11.3.394

Fig. 1. (A) Comparison of serum EDN levels measured by the K-EDN kit among severe asthmatics, nonsevere asthmatics, and NCs. (B) Comparison of serum EDN levels measured by the MBL kit between severe asthmatics, nonsevere asthmatics, and NCs.

Fig. 1

EDN, eosinophil-derived neurotoxin; NC, normal control.